EP2295056
Use of SNS-595 for treating leukemia
:
EP einkaleyfi: Þýðing ekki lögð inn:
14.3.2005:
6.1.2016:
10177951.0
:
13.3.2025
:
Use of SNS-595 for treating leukemia
14.3.2005
6.1.2016
:
Sunesis Pharmaceuticals, Inc.:
395 Oyster Point Blvd., Suite 400, 94080, South San Francisco, CA, US
:
Sumitomo Dainippon Pharma Co., Ltd.:
6-8, Dosho-machi 2-chome Chuo-ku, 541-8524, Osaka-shiOsaka, JP
:
Adelman, Daniel, C.:
Redwood City, CA, US
:
Silverman, Jeffrey A.:
Burlingame, CA, US
:
MASARU, Higaki:
Osaka-shi, Osaka, JP
:
SATOSHI, Nakao:
Osaka-shi, Osaka, JP
:
553578 P:
15.3.2004:
US
:
A61K 31/44, A61P 35/00, A61P 35/02, A61K 38/18, A61K 9/00, A61K 31/4745, A61K 31/555, A61K 31/4375, A61K 31/7068, A61K 41/00, A61K 45/06, A61K 47/12, C07D 471/04